about
High soluble endoglin levels do not induce endothelial dysfunction in mouse aorta.An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic SteatohepatitisStatin therapy and plasma free fatty acids: a systematic review and meta-analysis of controlled clinical trials.Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell deathThe role of endoglin in atherosclerosis.Soluble endoglin, hypercholesterolemia and endothelial dysfunction.Statin therapy and plasma cortisol concentrations: A systematic review and meta-analysis of randomized placebo-controlled trials.Statin impact on disease activity and C-reactive protein concentrations in systemic lupus erythematosus patients: A systematic review and meta-analysis of controlled trials.Soluble endoglin modulates the pro-inflammatory mediators NF-κB and IL-6 in cultured human endothelial cells.Effect of ezetimibe on plasma adipokines: a systematic review and meta-analysis.Synchronized activity of organic cation transporter 3 (Oct3/Slc22a3) and multidrug and toxin extrusion 1 (Mate1/Slc47a1) transporter in transplacental passage of MPP+ in rat.Aryl hydrocarbon receptor and aryl hydrocarbon nuclear translocator expression in human and rat placentas and transcription activity in human trophoblast cultures.Expression and activity of vitamin D receptor in the human placenta and in choriocarcinoma BeWo and JEG-3 cell lines.Direct administration of rutin does not protect against catecholamine cardiotoxicity.Examination of Glucocorticoid receptor alpha-mediated transcriptional regulation of P-glycoprotein, CYP3A4, and CYP2C9 genes in placental trophoblast cell lines.Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo.Synthesis, antimicrobial evaluation and molecular modeling of 5-hydroxyisoquinolinium salt series; the effect of the hydroxyl moiety.Vimentin expression during altered spermatogenesis in rats.Boldine enhances bile production in rats via osmotic and farnesoid X receptor dependent mechanisms.Cardiac biomarkers in a model of acute catecholamine cardiotoxicity.Analysis of accumulation of 99mTc-octreotide and 99mTc-EDDA/HYNIC-Tyr3-octreotide in the rat kidneys.Application of stereological methods for the quantification of VCAM-1 and ICAM-1 expression in early stages of rabbit atherogenesis.The changes in the endothelial expression of cell adhesion molecules and iNOS in the vessel wall after the short-term administration of simvastatin in rabbit model of atherosclerosis.The effects of lactoferrin in a rat model of catecholamine cardiotoxicity.Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice.MDOC and atorvastatin have potential antiinflammatory effects in vascular endothelium of apoE-/- mouse model of atherosclerosis.Cell adhesion molecules and eNOS expression in aorta of normocholesterolemic mice with different predispositions to atherosclerosis.Endothelial expression of endoglin in normocholesterolemic and hypercholesterolemic C57BL/6J mice before and after atorvastatin treatment.High soluble endoglin levels do not induce changes in structural parameters of mouse heart.High Levels of Soluble Endoglin Induce a Proinflammatory and Oxidative-Stress Phenotype Associated with Preserved NO-Dependent Vasodilatation in Aortas from Mice Fed a High-Fat Diet.Iron depletion induces hepatic secretion of biliary lipids and glutathione in rats.Spirulina platensis and phycocyanobilin activate atheroprotective heme oxygenase-1: a possible implication for atherogenesis.Atorvastatin slows down the deterioration of inner ear function with age in mice.Characterisation of Atherogenic Effects of Low Carbohydrate, High Protein Diet (LCHP) in ApoE/LDLR-/- Mice.Endoglin as a possible marker of atorvastatin treatment benefit in atherosclerosis.Organic Cation Transporter 3 (OCT3/SLC22A3) and Multidrug and Toxin Extrusion 1 (MATE1/SLC47A1) Transporter in the Placenta and Fetal Tissues: Expression Profile and Fetus Protective Role at Different Stages of Gestation1Activation of TGF-β Receptors and Smad Proteins by Atorvastatin is Related to Reduced Atherogenesis in ApoE/LDLR Double Knockout MiceCholesterol Effects on Endoglin and Its Downstream Pathways in ApoE/LDLR Double Knockout MiceModification of hepatic iron metabolism induced by pravastatin during obstructive cholestasis in ratsLetter by Vítek et al Regarding Article, “Niacin Inhibits Vascular Inflammation via the Induction of Heme Oxygenase-1”
P50
Q35175742-82619AC9-A255-4623-848D-053E858AD72AQ36071135-F2289061-C06D-4089-9333-5582B8A3E6C0Q36806626-F44A780F-F355-4C23-8D16-8656716F2046Q37330749-31DE43D2-ED5C-4935-95FC-E5C9151F0821Q37998302-2918156A-137F-4B6A-9C36-34DC9104EC43Q38621264-C94A4905-EAB0-4102-A4DF-934CE87E6585Q38627635-C385A9D4-4490-40B3-B470-EAB711BDFA48Q38690895-A615CBC6-24AB-4083-AD5A-2EE1EB340E29Q38710934-7A9BC5F7-9AC8-4F98-AA7C-7F2DA69C7782Q38976172-DD9DA093-B41D-4700-B0F5-F38CB6A33CA7Q39356896-61545103-291B-47B5-8189-DEEA56C249C3Q39526070-F494E984-B8CB-40B9-8C8A-82C93C62BF97Q39897223-AD44544B-31AC-4E35-A01B-B3624C04832FQ39920006-3A77FB88-590C-4BEF-98BA-18C70B200504Q40119245-C26C457D-C757-4A59-84BC-6591488DD6D0Q40323422-CE871BE7-2C25-4A94-811C-BF994CB5DBBBQ40972566-735E4DA5-685E-43DF-BD06-CB6488001870Q42483493-A29711AE-EFB6-4038-B259-19CA55E925C4Q42702286-22992F3E-ADE9-4C7F-9581-F246721B19BEQ43265423-9603B264-4D26-449E-B3D2-94C6CB484F50Q44794920-57999967-77D2-4B85-80B5-568ABD98C35BQ44938980-A6C93FF2-8D44-4CCF-A127-FA13403C706BQ45273763-96E1F891-4E98-4B25-845D-7A01386ABC62Q46265991-110D88C3-3B01-4010-8F57-DD2047C5B62DQ46741916-BB6F8886-A853-4258-8F63-7AEC76F5658DQ46818115-992D5B2A-8B0D-42C7-A413-38FBF06586AEQ46918588-52CF79AD-F823-4702-89D6-3D60B9D41257Q46976978-165947B4-19FB-4D4B-8AC4-B614782C5100Q47802388-8F7B1FF1-0137-4331-B581-4C830EE380FFQ47985408-1B6551E2-B534-44A6-AF4C-F3D45D586B70Q50185680-153599FC-2647-4556-8E75-1BE524A62A7BQ50229330-60F20261-9842-44A7-816E-0621E1BEA11DQ50460845-BFE27605-74CF-424D-AE2D-3ECBA27D8718Q50953166-AFDBE059-1D36-4453-8B9A-88847E8DDFAAQ54600902-41BC34FA-29BF-48DC-9B49-3B81B34600D5Q54601113-7C99E9DC-1EAB-45C9-8A31-8BBC8F019759Q54601126-C08FCB4D-DAE5-4513-8703-36EF84A0B87EQ54601168-72A88488-688B-4F07-9B62-16556E547536Q54601194-1136E4FC-68EE-4FAF-BD15-122E46D7C469Q63400463-7FE05B7E-5901-43D6-83F4-F049D15B8D6E
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Petr Nachtigal
@ast
Petr Nachtigal
@en
Petr Nachtigal
@es
Petr Nachtigal
@nl
Petr Nachtigal
@sl
type
label
Petr Nachtigal
@ast
Petr Nachtigal
@en
Petr Nachtigal
@es
Petr Nachtigal
@nl
Petr Nachtigal
@sl
prefLabel
Petr Nachtigal
@ast
Petr Nachtigal
@en
Petr Nachtigal
@es
Petr Nachtigal
@nl
Petr Nachtigal
@sl
P1053
S-8022-2017
P106
P1153
6505811498
P21
P31
P3829
P496
0000-0001-9568-7295